Bio@SNS Laboratory, Scuola Normale Superiore, Pisa, Italy.
Bio@SNS Laboratory, Scuola Normale Superiore, Pisa, Italy.
Neurobiol Dis. 2018 Mar;111:36-47. doi: 10.1016/j.nbd.2017.12.004. Epub 2017 Dec 12.
α-synuclein (αS) is a small protein that self-aggregates into α-helical oligomer species and subsequently into larger insoluble amyloid fibrils that accumulate in intraneuronal inclusions during the development of Parkinson's disease. Toxicity of αS oligomers and fibrils has been long debated and more recent data are suggesting that both species can induce neurodegeneration. However while most of these data are based on differences in structure between oligomer and aggregates, often preassembled in vitro, the in vivo situation might be more complex and subcellular locations where αS species accumulate, rather than their conformation, might contribute to enhanced toxicity. In line with this observation, we have shown that αS oligomers and aggregates are associated with the endoplasmic reticulum/microsomes (ER/M) membrane in vivo and how accumulation of soluble αS oligomers at the ER/M level precedes neuronal degeneration in a mouse model of α-synucleinopathies. In this paper we took a further step, investigating the biochemical and functional features of αS species associated with the ER/M membrane. We found that by comparison with non-microsomal associated αS (P10), the ER/M-associated αS pool is a unique population of oligomers and aggregates with specific biochemical traits such as increased aggregation, N- and C-terminal truncations and phosphorylation at serine 129. Moreover, when administered to murine primary neurons, ER/M-associated αS species isolated from diseased A53T human αS transgenic mice induced neuronal changes in a time- and dose-dependent manner. In fact the addition of small amounts of ER/M-associated αS species from diseased mice to primary cultures induced the formation of beads-like structures or strings of fibrous αS aggregates along the neurites, occasionally covering the entire process or localizing at the soma level. By comparison treatment with P10 fractions from the same diseased mice resulted in the formation of scarce and small puncta only when administered at high amount. Moreover, increasing the amount of P100/M fractions obtained from diseased and, more surprisingly, from presymptomatic mice induced a significant level of neuronal death that was prevented when neurons were treated with ER/M fractions immunodepleted of αS high molecular weight (HMW) species. These data provide the first evidence of the existence of two different populations of αS HMW species in vivo, putting the spotlight on the association to ER/M membrane as a necessary step for the acquisition of αS toxic features.
α-突触核蛋白(αS)是一种小蛋白,可自组装成 α-螺旋寡聚物,然后进一步组装成不溶性淀粉样纤维,在帕金森病的发展过程中在神经元内蓄积。αS 寡聚物和纤维的毒性一直存在争议,最近的数据表明,这两种物质都可以诱导神经退行性变。然而,尽管这些数据大多基于寡聚物和聚集体之间的结构差异,这些结构通常是在体外预先组装的,但体内情况可能更为复杂,αS 聚集体在细胞内的蓄积部位,而不是其构象,可能有助于增强毒性。与这一观察结果一致的是,我们已经表明,αS 寡聚物和聚集体与内质网/微粒体(ER/M)膜在体内相关,以及可溶性 αS 寡聚物在 ER/M 水平的积累如何先于 α-突触核蛋白病小鼠模型中的神经元变性。在本文中,我们更进一步,研究了与 ER/M 膜相关的 αS 物种的生化和功能特征。我们发现,与非微粒体相关的 αS(P10)相比,ER/M 相关的 αS 池是一种独特的寡聚物和聚集体群体,具有特定的生化特征,如聚集增加、N 和 C 末端截断以及丝氨酸 129 的磷酸化。此外,当将来自患病 A53T 人类 αS 转基因小鼠的 ER/M 相关 αS 物种施用于原代神经元时,它们以时间和剂量依赖的方式诱导神经元变化。事实上,将来自患病小鼠的少量 ER/M 相关 αS 物种添加到原代培养物中,会沿着神经突形成珠状结构或纤维状 αS 聚集体的串,偶尔会覆盖整个过程或定位于胞体水平。相比之下,用来自同一患病小鼠的 P10 部分处理只会在高剂量时形成少量和小的点状结构。此外,增加来自患病和更令人惊讶的是,来自亚临床期小鼠的 P100/M 部分的量会导致神经元死亡显著增加,而当用免疫耗尽 αS 高分子量(HMW)物种的 ER/M 部分处理神经元时,这种神经元死亡会被阻止。这些数据首次提供了体内存在两种不同的 αS HMW 物种的证据,并将焦点放在与 ER/M 膜的关联上,这是获得 αS 毒性特征的必要步骤。